The Community
Doubling Down on
Kidney Health  

Welcome to KidneyDAO, a community-owned network funding groundbreaking research to advance kidney health. Together, we're accelerating innovation, improving care access, and transforming treatment options to reverse Chronic Kidney Disease (CKD) progression.

The Silent Epidemic:
Kidney Disease Today

As conditions like diabetes and high blood pressure rise at an alarming rate, we face an unprecedented challenge in kidney health. While medical advances help people live longer, access to early detection and specialized treatment remains out of reach for the vast majority.

Cases of kidney disease are on the rise

800 million people suffer from chronic kidney disease (CDK) worldwide, over 10% of our population.

Inaccessible treatment costs

Treatment costs per individual for CDK are $100,000 annually in the US, with medicare spending reaching 130B.

Disparities
in Care

Only 20-30% of people with early-stage kidney disease are diagnosed.

Our Mission

Tackling the silent killer - kidney diseases - with the power of our global community!

A Human Centered Approach

Our Human-Centered Approach puts patients first, focusing on reversing CKD progression, reducing treatment costs, and advancing innovative transplant solutions. We improve care accessibility and combat organ trafficking, ensuring kidney health innovations reach everyone who needs them.

Empowering our Community

Decentralized Science drives our innovative approach to kidney health research, uniting a global network of experts and advocates. Through transparent funding and open collaboration, we accelerate breakthroughs from research to real-world treatments.

Accelerating
Research

Our global community democratizes and accelerates kidney health research through rapid funding of promising projects, ensuring breakthroughs reach everyone worldwide.

Project Proposals

KLF15 Agonist Phase I
KLF15 Agonist Phase I

The KLF15 Agonist Phase I project targets albuminuria in chronic kidney disease, offering a potentially safer and more effective alternative to glucocorticoid therapy for conditions like FSGS and MCD. With promising efficacy and reduced toxicity, this novel approach is progressing towards patent licensing and IND roadmap development, aiming for accelerated FDA approval.

View project

FDA Cleared Patented Facial RPM AI
FDA Cleared Patented Facial RPM AI

Smartphone-based Facial remote patient management (RPM) AI, providing an affordable alternative to costly monitoring devices. FDA-cleared and patent-protected, it targets conditions like hypertension and CKD. Ready for deployment, it aims to revolutionize personalized medicine, beginning with mental health.

View project

Decentralized Independent Physician Association (DeIPA)
Decentralized Independent Physician Association (DeIPA)

KidneyDAO's DeIPA is a revolutionary model that demonstrates the potential of CareYield's platform. By leveraging blockchain technology, artificial intelligence, and tokenization, DeIPA has addressed the limitations of traditional IPAs, unlocking new opportunities for growth, efficiency, and patient care.

View project

CareToken: Unlocking the Potential of Healthcare Assets
CareYield: Unlocking the Potential of Healthcare Assets

CareYield leverages blockchain, AI, and community to tokenize healthcare assets, creating a liquid marketplace. It aims to accelerate innovation, improve outcomes, and reduce costs, targeting crypto investors while maintaining regulatory compliance.

View project

Intel MedPatch AI
Intel MedPatch AI

Intel MedPatch AI tackles medication non-compliance through automated lab testing and microneedle drug delivery. This system aims to reduce healthcare costs and medication errors, especially for elderly and rural patients. With patents for CKD and CHF, an obesity management grant, and potential Epogen partnership, it's progressing towards wider application.

View project

Dialysis AI Humanoid Robotic Staffing
Dialysis AI Humanoid Robotic Staffing

The Dialysis AI Humanoid Robotic Staffing project tackles the nephrology professional shortage through an AI-driven staffing platform, patient-provider matching app, and humanoid robots. With a revenue-generating platform already operational and patent-pending AI and robotic solutions in development, it aims to optimize dialysis care delivery and staffing efficiency.

View project

Our Partners and Networks

5M+

Diabetes Patient Data

1M+

CKD Patient Data

100K+

Active Users in Partner Network

The Future of Kidney Health

KidneyDAO tackles the global kidney health crisis through community-driven action. By leveraging blockchain technology for transparent funding, IP management, and AI innovation, KNEY token holders help select research projects and participate in governance decisions that will drive scientific advancement in kidney health and longevity.

Related News

Youtube

Musing With Morales

Musings With Morales is a thought-provoking podcast that delves into health, wellness, technology, entrepreneurship, mindset, and, personal and professional growth.

Medium

The Future of Dialysis: How Humanoid Robots, Web3, Metaverser, and AI Can Bridge the Staffing Gap Through M&A Strategies

by London Nguyen, MD, MMM, and Tuan Dinh, PhD

Medium

Transforming Self-Care: How KidneyDAO’s Kidney GPT, FDA-Cleared RPM AI, Nurse Line 24/7 Backed By Licensed Physicians Are Revolutionizing Healthcare

by London Nguyen, MD, MMM, and Tuan Dinh, PhD

Transforming Self-Care

Join the community 
advancing kidney health

For Contributors

Find out how you can contribute your skills toward the future of kidney health.

Get involved

For Members

Join the global community committed to advancing kidney health.

Become a member

For Researchers

Learn more about how KidneyDAO can help accelerate your research.

Apply for funding

General FAQ